Vimarsana
Biggest News Aggregation in the World

Page 17 - Manufacturing Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Manufacturing Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Manufacturing Program Today - Breaking & Trending Today

'Made in India' mobile phone shipments cross 2 billion units mark between 2014-22: Counterpoint, ET Telecom - Vimarsana News

'Made in India' mobile phone shipments cross 2 billion units mark between 2014-22: Counterpoint, ET Telecom

Mobile Phone Shipments: As a result, India has become the second-biggest phone-producing country, the research firm said.

Saturday brings out back-to-school spirit - Vimarsana News

Saturday brings out back-to-school spirit

As the summer vacation of 2023 comes to a (far too early) close, this past Saturday saw a series of back-to-back-to-back celebrations and school supply giveaways all over town catering

Design and innovation play a key role in making India a powerhouse of consumer and electronics manufacturing - Vimarsana News

Design and innovation play a key role in making India a powerhouse of consumer and electronics manufacturing

India’s prowess in various sectors has positioned it as a formidable global force, with its potential to become a powerhouse in consumer and electronics manufacturing undeniable. To fully harness this potential, the twin pillars of...

FAME II - Vimarsana News

FAME II

Thousands of words have been written on the rights and wrongs of the Government of India ‘reducing” the subsidy under the Faster Adoption and Manufacturing of Electric Vehicles phase 2 – FAME II for electric...

Registrational Pivotal Phase III Study of Olverembatinib for the First-Line Treatment of Patients with Ph+ ALL Approved by the CDE in China - Vimarsana News

Registrational Pivotal Phase III Study of Olverembatinib for the First-Line Treatment of Patients with Ph+ ALL Approved by the CDE in China

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and...